Live tape
Top 8, mentions 7d15,739MSFT3,098 mentions▲ +0.09GOOGL2,177 mentions▲ +0.05AAPL2,131 mentions▲ +0.07META2,089 mentions▲ +0.04SNDK1,844 mentions▲ +0.06NVDA1,604 mentions▲ +0.07SPCX1,560 mentions▲ +0.06QQQ1,236 mentions▲ +0.04

Equity · Healthcare

NVST

Envista Holdings Corporation · NYSE

$26.74 −0.93% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of NVST over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $26.00 on 4 May 2026 through $26.74 on 17 July 2026. Finazon · prior-day close.

Market cap $4.4B
P/E (TTM) 86.3
52-week range $19.00 – $30.17
Avg volume 705.1K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

NVST insider trades

SEC Form 4 · last 90 days · newest reported trade 25 May 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 8
Compensation mechanics (8 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
25 May 2026 Keel Paul A Chief Executive Officer Tax withheld 12,811 $300K
19 May 2026 Carruthers Wendy Director Award 9,330
19 May 2026 TSINGOS CHRISTINE A Director Award 9,330
19 May 2026 Raskas Daniel Director Award 9,330
19 May 2026 GALLAHUE KIERAN Director Award 9,330
19 May 2026 Huennekens R Scott Director Award 12,585
19 May 2026 Jain Vivek Director Award 9,330
19 May 2026 Pierce James Andrew Director Award 9,330

NVST reported financials

SEC EDGAR XBRL

NVST reported revenue of $2.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $47.0M.

Figure Reported Period
Revenue $2.7B 31 Dec 2025 fiscal year
Net income $47.0M 31 Dec 2025 fiscal year
Diluted EPS $0.28 31 Dec 2025 fiscal year
Total assets $5.6B 03 Apr 2026 at period end
Total equity $3.1B 03 Apr 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 03 Apr 2026

NVST earnings

SEC EDGAR
Date Period EPS Revenue
03 Apr 2026 Q1 2026 $0.23 —
31 Dec 2025 FY 2025 $0.28 —
26 Sep 2025 Q3 2025 $-0.18 —
27 Jun 2025 Q2 2025 $0.16 —

Reported figures & scheduled dates · SEC EDGAR filings

NVST institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a NVST position for the quarter ended 31 Mar 2026 — a combined $219.4M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Citadel Advisors Added +138.6% shares 4,584,572 $116.3M
AQR Capital Management Held (±25%) +11.1% shares 2,618,117 $65.1M
Renaissance Technologies Added +195.9% shares 1,208,165 $30.7M
Two Sigma Investments New position 126,100 $3.2M
Bridgewater Associates Trimmed −38.4% shares 76,437 $1.9M
Man Group Added +185.2% shares 47,469 $1.2M
D. E. Shaw & Co. Trimmed −67.0% shares 17,292 $439K
Tudor Investment Corp Trimmed −37.2% shares 11,619 $295K
Marshall Wace Trimmed −92.5% shares 10,874 $276K
Balyasny Asset Management Exited

Source: SEC EDGAR 13F filings

NVST fails-to-deliver

SEC CNS data

On 30 Jun 2026, 18 shares of NVST failed to deliver (about $486).

Settlement date Shares failed Notional % of shares out
30 Jun 2026 18 $486 <0.001%
25 Jun 2026 184 $5K <0.001%
24 Jun 2026 805 $20K <0.001%
23 Jun 2026 34,868 $889K 0.021%
22 Jun 2026 937 $24K 0.001%
18 Jun 2026 336 $8K <0.001%

Source: SEC fails-to-deliver (CNS) data